PFG
37
3
SHW
61
3
UNH
36
-13
AIV
53
-2
SLB
37
5
MLM
72
2
PEP
36
3
HCP
62
-2
NWS
69
-4
BAX
35
2
DG
32
6
FAST
45
3
MKC
35
3
MRK
56
-7
CPB
42
5
ETN
78
5
KIM
48
10
PG
58
3
CA
40
-4
TRV
42
3
PFG
37
3
SHW
61
3
UNH
36
-13
AIV
53
-2
SLB
37
5
MLM
72
2
PEP
36
3
HCP
62
-2
NWS
69
-4
BAX
35
2
DG
32
6
FAST
45
3
MKC
35
3
MRK
56
-7
CPB
42
5
ETN
78
5
KIM
48
10
PG
58
3
CA
40
-4
TRV
42
3
Financhill
Back

Repligen Stock Predictions

Sell
40

RGEN
Repligen

Last Price:
124.23
Seasonality Move:
6.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Repligen Stock Forecast

  • Over the next 52 weeks, Repligen has on average historically risen by 20.8% based on the past 38 years of stock performance.
  • Repligen has risen higher in 21 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.26%
  • Is Repligen Stock Undervalued?
    The current Repligen [RGEN] share price is $124.35. The Score for RGEN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Repligen Stock Go Up Next Year?

  • Over the next 52 weeks, Repligen has on average historically risen by 20.8% based on the past 38 years of stock performance.

Repligen Stock Rating

Sell
40
Repligen (RGEN) is a Sell

Is Repligen overpriced?

  • Repligen has risen higher in 21 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.26%

Repligen Stock Price History

Is RGEN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
repligen.com

52-Week Data

52-Week High:
211.13
52-Week Low:
110.45

Prediction Charts

Market Cap:
6.95B
Price in USD:
124.35
Volume:
1.18M
Beta:
0.98

Technical Analysis

SMA50:
159.90
SMA100:
176.74
SMA200:
168.74
52-Wk Change:
-21.03%

Stock Predictions

  • Is Repligen stock public?
    Yes, Repligen is a publicly traded company.
  • What is the Repligen stock quote today?
    The Repligen stock price is 124.35 USD today.
  • How to buy Repligen stock online?
    You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-29 153.84 152.06 155.30 150.76
May-30 149.99 148.18 150.65 147.00
May-31 149.89 149.10 151.38 147.48
Jun-3 150.61 150.35 153.11 148.49
Jun-4 150.18 147.75 150.92 147.13
Jun-5 148.85 150.70 153.54 144.84
Jun-6 150.70 148.54 154.02 148.29
Jun-7 146.85 145.78 148.09 145.08
Jun-10 143.07 141.08 144.74 141.05
Jun-11 140.52 140.68 142.89 138.42
Jun-12 144.37 142.81 144.44 141.01
Jun-13 136.00 125.94 138.26 125.02
Jun-14 125.45 125.62 126.41 122.92
Jun-17 127.60 124.35 129.86 123.37

Repligen Earnings

Repligen Earnings Report: Per Share Repligen Earnings Q1 Q2 Q3 and Q4 last year and next year.

Repligen Forecast Revenue Growth

Repligen Stock Analysis: Historical quarterly revenues per share for Repligen and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.28 per share, and an increase next year of $0.56 per share.

* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.